OR WAIT null SECS
Long-Term Considerations in Angle Closure Glaucoma with Lauren Blieden, MD
Blieden discusses long-term patient management in glaucoma, the importance of follow-up care, and the role of advocacy in ophthalmology.
As glaucoma research evolves, long-term patient outcomes remain a key focus, particularly in angle closure cases. With critical gaps in long-term data, clinicians are refining management strategies while awaiting further research to guide best practices.
In a recent interview with HCPLive, Lauren Blieden, MD, a professor of ophthalmology at Baylor College of Medicine, highlighted critical updates in patient management, the role of patient education, and the importance of advocacy in ophthalmology. Blieden presented a talk entitled "Glaucoma/Narrow Angles” at the Texas Ophthalmological Association (TOA) Annual Meeting in Houston, Texas.
Long-term follow-up data from the EAGLE trial remains a key area of interest in glaucoma research, particularly regarding the progression of angle closure as patients age. With nearly a decade since its publication, ophthalmologists are eager for updates to guide long-term management strategies. Blieden shared insights from her clinical experience, noting that while stable patients can often be monitored less frequently, uncertainties remain about disease progression in older age groups.
Blieden emphasized the importance of patient education, especially in diverse populations with a higher prevalence of angle closure. Early symptom recognition—such as sudden headaches or vision changes—can prevent delays in care. She also highlighted the need for patient awareness regarding medication-related risks and the importance of seeking specialized ophthalmic care rather than general emergency services in acute cases.
Blieden noted the Texas Ophthalmological Association (TOA), recently renamed the Texas Society of Eye Physicians and Surgeons, continues to serve as a vital platform for both clinical education and ophthalmic advocacy. Smaller meetings facilitate in-depth discussions on emerging research, case studies, and legislative issues, including scope-of-practice regulations and liability concerns.
Blieden reports no relevant disclosures.
References
